Monthly Archives: November 2024

When Will Retatrutide Be Available FDA APPROVED Retatrutide is still in clinical trials and is not yet available for prescription. It’s currently undergoing Phase 3 trials, the last stage before potentially seeking FDA approval.   Here’s a breakdown of the expected timeline Important Note: Currently, the only way to access retatrutide is through participation in clinical trials. […]

There are several other promising weight loss drugs currently in Phase 3 clinical trials, besides retatrutide .  Here’s a list highlighting some of the key candidates This list is not exhaustive, and new candidates are constantly entering the pipeline. It’s a rapidly developing area, and these medications could offer additional options for weight management in […]

Eli Lilly currently has one FDA-approved drug specifically for weight loss: Zepbound contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps reduce appetite and food intake, leading to weight loss. It is recommended to use Zepbound in conjunction with a reduced-calorie diet and increased physical activity.  Important notes about Zepbound Eli Lilly’s pipeline […]